Maternal and Fetal Factors Associated with Mortality and Morbidity in a Multi-Racial/Ethnic Registry of Anti-SSA/Ro Associated Cardiac Neonatal Lupus

Documenti analoghi

• Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system
  di: Izmirly, Peter M, et al.
  Pubblicazione: (2015)
• Maternal Use of Hydroxychloroquine is Associated with a Reduced Risk of Recurrent Anti-SSA/Ro Associated Cardiac Manifestations of Neonatal Lupus
  di: Izmirly, Peter M., et al.
  Pubblicazione: (2012)
• Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
  di: Izmirly, Peter M, et al.
  Pubblicazione: (2010)
• Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus
  di: Saxena, Amit, et al.
  Pubblicazione: (2015)
• Beta2-glycoprotein-I and Protection from Anti-SSA/Ro 60 Associated Cardiac Manifestations of Neonatal Lupus
  di: Reed, Joanne H., et al.
  Pubblicazione: (2011)